PANE, FABRIZIO
PANE, FABRIZIO
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study
2007 Baccarani, M; Cilloni, D; Rondoni, M; Ottaviani, E; Messa, F; Merante, S; Tiribelli, M; Buccisano, F; Testoni, N; Gottardi, E; DE VIVO, A; Giugliano, E; Iacobucci, I; Paolini, S; Soverini, S; Rosti, G; Rancati, F; Astolfi, C; Pane, Fabrizio; Saglio, G; Martinelli, G.
Coexistence of two distinct cell populations (CD56+TcRgd+ and CD56+TcRgd-) in a case of aggressive CD56+ lymphoma/leukemia
2000 Camera, A.; Pezzullo, L.; Villa, M. R.; Luciano, L.; Pane, Fabrizio; Izzo, Barbara; Boccuni, P.; DI NOTO, R.; DEL VECCHIO, L.; Salvatore, F.; Rotoli, B.
BCR/ABL mRNA and the P210BCR/ABL protein are down-modulated by Interferon-alpha in chronic myeloid leukemia patients
1999 Pane, Fabrizio; Mostarda, I.; Selleri, C.; Salzano, R.; Raiola, A. M.; Luciano, L.; Saglio, G.; Rotoli, B.; Salvatore, F.
Fas-mediated modulation of Bcr/Abl in choronic myelogenous leukemia results in differential effects on apoptosis
1998 Selleri, C.; Maciejewski, J. P.; Pane, Fabrizio; Luciano, L.; Raiola, A. M.; Mostarda, I; Salvatore, F.; Rotoli, Bruno
In vitro acquired cellular senescence and aging-specific phenotype can be distinguished on the basis of specific mRNA expression
2002 Faraonio, Raffaella; Pane, Fabrizio; Intrieri, M; Russo, T; AND CIMINO, F.
Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course.
2002 Verstovsek, S.; Lin, H.; Kantarjian, H.; Saglio, G.; DE MICHELI, D.; Pane, Fabrizio; GARCIA MANERO, G.; Intrieri, M.; Rotoli, B.; Salvatore, F.; Guo, J. Q.; Talpaz, M.; Specchia, G.; Pizzolo, G.; Liberati, A. M.; Cortes, J.; Quackenbush, R. C.; Arlinghaus, R. B.
Decitabine up-regulates the expression of the cancer-associate prame antigen in early chronic phase CML cells.
2003 Pane, Fabrizio; Quintarelli, Concetta; Izzo, Barbara; Martinelli, G.; Intrieri, M.; Luciano, L.; Amabile, M.; Rosti, G.; Saglio, G.; Baccarani, M.; Salvatore, F.
Preferentially expressed antigen of melanoma (PRAME)-specific cytotoxic T-Lymphocytes (CTLs) and transgenic T cells to target chronic myelogenous leukemia (CML)
2007 Quintarelli, Concetta; . Dotti G, .; De Angelis, B.; Pane, Fabrizio; Savoldo, B.
CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.
2011 Iacobucci, I; Ferrari, A; Lonetti, A; Papayannidis, C; Paoloni, F; Trino, S; Storlazzi, Ct; Ottaviani, E; Cattina, F; Impera, L; Abbenante, Mc; Vignetti, M; Vitale, A; Potenza, L; Paolini, S; Soverini, S; Pane, Fabrizio; Luppi, M; Fo?, R; Baccarani, M; Martinelli, G.
Acute promyelocytic leukemia after treatment for non-Hodgkin lymphoma with drugs targeting topoisomerase II.
1999 DE RENZO, A.; Santoro, L. F. E.; Notaro, R.; Pane, Fabrizio; Buonaiuto, M. R.; Luciano, L.; Rotoli, B.
Induction of PRAME-specific immunity by overlapping pentadecapeptides in patients with hematologic malignancies
2009 Quintarelli, Concetta; DE ANGELIS, Biagio; G., Dotti; L., Luciano; H., Heslop; C., Rooney; M., Brenner; B., Savoldo; Pane, Fabrizio
In vitro acquired cellular senescence and aging-specific phenotype can be distinguished on the basis of specific mRNA expression.
2002 Faraonio, F.; Pane, Fabrizio; Intrieri, M.; Russo, T.; Cimino, F.
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia
2007 Cilloni, D; Messa, F; Martinelli, G; Gottardi, E; Arruga, F; Defilippi, I; Carturan, S; Messa, E; Fava, M; Giugliano, E; Rosso, V; Catalano, R; Merante, S; Nicoli, P; Rondoni, M; Ottaviani, E; Soverini, S; Tiribelli, M; Pane, Fabrizio; Baccarani, M; Saglio, G.
Lymph node fine needle cytology in the staging and follow-up of cutaneous lymphomas.
2014 Vigliar, Elena; Cozzolino, I; Picardi, Marco; Peluso, Al; Fernandez, Lv; Vetrani, Antonio; Botti, G; Pane, Fabrizio; Selleri, C; Zeppa, P. 1.
Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia.
2013 Quintarelli, Concetta; DE ANGELIS, Biagio; Errichiello, S; Caruso, S; Esposito, N; Colavita, I; Raia, M; Pagliuca, S; Pugliese, N; Risitano, ANTONIO MARIA; Picardi, Marco; Luciano, L; Saglio, G; Martinelli, G; Pane, Fabrizio
Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.
2010 Ferrara, F; Izzo, T; Criscuolo, C; Riccardi, C; Muccioli, G; Viola, A; Pane, Fabrizio; Palmieri, S.
Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis.
2010 Castagnetti, F; Testoni, N; Luatti, S; Marzocchi, G; Mancini, M; Kerim, S; Giugliano, E; Albano, F; Cuneo, A; Abruzzese, E; Martino, B; Palandri, F; Amabile, M; Iacobucci, I; Alimena, G; Pane, Fabrizio; Martinelli, G; Saglio, G; Baccarani, M; Rosti, G.
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase.
2010 Palandri, F; Castagnetti, F; Iacobucci, I; Martinelli, G; Amabile, M; Gugliotta, G; Poerio, A; Testoni, N; Breccia, M; Bocchia, M; Crugnola, M; Rege Cambrin, G; Martino, B; Pierri, I; Radaelli, F; Specchia, G; Pane, Fabrizio; Saglio, G; Rosti, G; Baccarani, M.
characterisation of two novel cell lines, DERL-2 (CD56+/CD3+/TCR gammadelta+) and DERL-7 (CD56+/CD3-/TCR gammadelta-) derived from a single patient with CD56+ non Hodgkin lymphoma
2001 DI NOTO, R.; Pane, Fabrizio; Camera, A.; Luciano, L.; Barone, M.; LO PARDO, C.; Boccuni, P.; Intrieri, M.; Rotoli, Bruno; Sacchetti, L; Salvatore, F.; DEL VECCHIO, L.
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase.
2010 Palandri, F.; Castagnetti, F.; Iacobucci, I.; Martinelli, G.; Amabile, M.; Gugliotta, G.; Poerio, A.; Testoni, N.; Breccia, M.; Bocchia, M.; Crugnola, M.; Rege Cambrin, G.; Martino, B.; Pierri, I.; Radaelli, F.; Specchia, G.; Pane, Fabrizio; Saglio, G.; Rosti, G.; Baccarani, M.
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study | 1.1 Articolo in rivista | 2007 | Baccarani, M; Cilloni, D; Rondoni, M; Ottaviani, E; Messa, F; Merante, S; Tiribelli, M; Buccisano, F; Testoni, N; Gottardi, E; DE VIVO, A; Giugliano, E; Iacobucci, I; Paolini, S; Soverini, S; Rosti, G; Rancati, F; Astolfi, C; Pane, Fabrizio; Saglio, G; Martinelli, G. | |
| Coexistence of two distinct cell populations (CD56+TcRgd+ and CD56+TcRgd-) in a case of aggressive CD56+ lymphoma/leukemia | 1.1 Articolo in rivista | 2000 | Camera, A.; Pezzullo, L.; Villa, M. R.; Luciano, L.; Pane, Fabrizio; Izzo, Barbara; Boccuni, P.; DI NOTO, R.; DEL VECCHIO, L.; Salvatore, F.; Rotoli, B. | |
| BCR/ABL mRNA and the P210BCR/ABL protein are down-modulated by Interferon-alpha in chronic myeloid leukemia patients | 1.1 Articolo in rivista | 1999 | Pane, Fabrizio; Mostarda, I.; Selleri, C.; Salzano, R.; Raiola, A. M.; Luciano, L.; Saglio, G.; Rotoli, B.; Salvatore, F. | |
| Fas-mediated modulation of Bcr/Abl in choronic myelogenous leukemia results in differential effects on apoptosis | 1.1 Articolo in rivista | 1998 | Selleri, C.; Maciejewski, J. P.; Pane, Fabrizio; Luciano, L.; Raiola, A. M.; Mostarda, I; Salvatore, F.; Rotoli, Bruno | |
| In vitro acquired cellular senescence and aging-specific phenotype can be distinguished on the basis of specific mRNA expression | 1.1 Articolo in rivista | 2002 | Faraonio, Raffaella; Pane, Fabrizio; Intrieri, M; Russo, T; AND CIMINO, F. | |
| Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course. | 1.1 Articolo in rivista | 2002 | Verstovsek, S.; Lin, H.; Kantarjian, H.; Saglio, G.; DE MICHELI, D.; Pane, Fabrizio; GARCIA MANERO, G.; Intrieri, M.; Rotoli, B.; Salvatore, F.; Guo, J. Q.; Talpaz, M.; Specchia, G.; Pizzolo, G.; Liberati, A. M.; Cortes, J.; Quackenbush, R. C.; Arlinghaus, R. B. | |
| Decitabine up-regulates the expression of the cancer-associate prame antigen in early chronic phase CML cells. | 1.5 Abstract in rivista | 2003 | Pane, Fabrizio; Quintarelli, Concetta; Izzo, Barbara; Martinelli, G.; Intrieri, M.; Luciano, L.; Amabile, M.; Rosti, G.; Saglio, G.; Baccarani, M.; Salvatore, F. | |
| Preferentially expressed antigen of melanoma (PRAME)-specific cytotoxic T-Lymphocytes (CTLs) and transgenic T cells to target chronic myelogenous leukemia (CML) | 1.5 Abstract in rivista | 2007 | Quintarelli, Concetta; . Dotti G, .; De Angelis, B.; Pane, Fabrizio; Savoldo, B. | |
| CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients. | 1.1 Articolo in rivista | 2011 | Iacobucci, I; Ferrari, A; Lonetti, A; Papayannidis, C; Paoloni, F; Trino, S; Storlazzi, Ct; Ottaviani, E; Cattina, F; Impera, L; Abbenante, Mc; Vignetti, M; Vitale, A; Potenza, L; Paolini, S; Soverini, S; Pane, Fabrizio; Luppi, M; Fo?, R; Baccarani, M; Martinelli, G. | |
| Acute promyelocytic leukemia after treatment for non-Hodgkin lymphoma with drugs targeting topoisomerase II. | 1.1 Articolo in rivista | 1999 | DE RENZO, A.; Santoro, L. F. E.; Notaro, R.; Pane, Fabrizio; Buonaiuto, M. R.; Luciano, L.; Rotoli, B. | |
| Induction of PRAME-specific immunity by overlapping pentadecapeptides in patients with hematologic malignancies | 1.5 Abstract in rivista | 2009 | Quintarelli, Concetta; DE ANGELIS, Biagio; G., Dotti; L., Luciano; H., Heslop; C., Rooney; M., Brenner; B., Savoldo; Pane, Fabrizio | |
| In vitro acquired cellular senescence and aging-specific phenotype can be distinguished on the basis of specific mRNA expression. | 1.1 Articolo in rivista | 2002 | Faraonio, F.; Pane, Fabrizio; Intrieri, M.; Russo, T.; Cimino, F. | |
| WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia | 1.1 Articolo in rivista | 2007 | Cilloni, D; Messa, F; Martinelli, G; Gottardi, E; Arruga, F; Defilippi, I; Carturan, S; Messa, E; Fava, M; Giugliano, E; Rosso, V; Catalano, R; Merante, S; Nicoli, P; Rondoni, M; Ottaviani, E; Soverini, S; Tiribelli, M; Pane, Fabrizio; Baccarani, M; Saglio, G. | |
| Lymph node fine needle cytology in the staging and follow-up of cutaneous lymphomas. | 1.1 Articolo in rivista | 2014 | Vigliar, Elena; Cozzolino, I; Picardi, Marco; Peluso, Al; Fernandez, Lv; Vetrani, Antonio; Botti, G; Pane, Fabrizio; Selleri, C; Zeppa, P. 1. | |
| Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia. | 1.1 Articolo in rivista | 2013 | Quintarelli, Concetta; DE ANGELIS, Biagio; Errichiello, S; Caruso, S; Esposito, N; Colavita, I; Raia, M; Pagliuca, S; Pugliese, N; Risitano, ANTONIO MARIA; Picardi, Marco; Luciano, L; Saglio, G; Martinelli, G; Pane, Fabrizio | |
| Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan. | 1.1 Articolo in rivista | 2010 | Ferrara, F; Izzo, T; Criscuolo, C; Riccardi, C; Muccioli, G; Viola, A; Pane, Fabrizio; Palmieri, S. | |
| Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis. | 1.1 Articolo in rivista | 2010 | Castagnetti, F; Testoni, N; Luatti, S; Marzocchi, G; Mancini, M; Kerim, S; Giugliano, E; Albano, F; Cuneo, A; Abruzzese, E; Martino, B; Palandri, F; Amabile, M; Iacobucci, I; Alimena, G; Pane, Fabrizio; Martinelli, G; Saglio, G; Baccarani, M; Rosti, G. | |
| The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase. | 1.1 Articolo in rivista | 2010 | Palandri, F; Castagnetti, F; Iacobucci, I; Martinelli, G; Amabile, M; Gugliotta, G; Poerio, A; Testoni, N; Breccia, M; Bocchia, M; Crugnola, M; Rege Cambrin, G; Martino, B; Pierri, I; Radaelli, F; Specchia, G; Pane, Fabrizio; Saglio, G; Rosti, G; Baccarani, M. | |
| characterisation of two novel cell lines, DERL-2 (CD56+/CD3+/TCR gammadelta+) and DERL-7 (CD56+/CD3-/TCR gammadelta-) derived from a single patient with CD56+ non Hodgkin lymphoma | 1.1 Articolo in rivista | 2001 | DI NOTO, R.; Pane, Fabrizio; Camera, A.; Luciano, L.; Barone, M.; LO PARDO, C.; Boccuni, P.; Intrieri, M.; Rotoli, Bruno; Sacchetti, L; Salvatore, F.; DEL VECCHIO, L. | |
| The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase. | 1.1 Articolo in rivista | 2010 | Palandri, F.; Castagnetti, F.; Iacobucci, I.; Martinelli, G.; Amabile, M.; Gugliotta, G.; Poerio, A.; Testoni, N.; Breccia, M.; Bocchia, M.; Crugnola, M.; Rege Cambrin, G.; Martino, B.; Pierri, I.; Radaelli, F.; Specchia, G.; Pane, Fabrizio; Saglio, G.; Rosti, G.; Baccarani, M. |